Northside Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Northside Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,380	Closed	-$311K	–	113
2022 Q3	$311K	Hold	4,380	–	–	0.1%	66
2022 Q2	$337K	Hold	4,380	–	–	0.11%	62
2022 Q1	$320K	Hold	4,380	–	–	0.09%	68
2021 Q4	$273K	Hold	4,380	–	–	0.07%	70
2021 Q3	$259K	Hold	4,380	–	–	0.07%	77
2021 Q2	$293K	Sell	4,380 -160	-4%	-$10.4K	0.07%	72
2021 Q1	$287K	Buy	4,540 +91	+2%	+$5.66K	0.08%	68
2020 Q4	$276K	Hold	4,449	–	–	0.08%	70
2020 Q3	$268K	Sell	4,449 -1,945	-30%	-$117K	0.09%	72
2020 Q2	$376K	Buy	+6,394	New	+$382K	0.13%	69
2018 Q3	–	Sell	-5,210	Closed	-$288K	–	58
2018 Q2	$288K	Buy	+5,210	New	+$281K	0.1%	52
2017 Q2	–	Sell	-6,619	Closed	-$360K	–	71
2017 Q1	$360K	Buy	+6,619	New	+$363K	0.1%	103

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northside Capital Management's BMY Position: Q4 2022 in Review

Northside Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 4,380 shares — an estimated $311K sold.

Northside Capital Management first reported a position in BMY in Q1 2017 and held it in 12 quarters. The position peaked at $376K in Q2 2020. 2,602 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

Northside Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
Northside Capital Management sold 4,380 Bristol-Myers Squibb shares in Q4 2022, an estimated $311K.
Northside Capital Management first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 12 quarters.
Northside Capital Management's Bristol-Myers Squibb position peaked at $376K in Q2 2020.
2,602 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Northside Capital Management's 13F filing for Q4 2022, filed 13 Jan 2023.